Ann Surg Oncol September 2024 PMID 38797790

Long-Term Survival Outcomes After Minimally Invasive Surgery for Ileal Neuroendocrine Tumors.

Akitada Yogo, Alan Paciorek, Yosuke Kasai, Farhana Moon, Kenzo Hirose, Carlos U Corvera, Emily K Bergsland, Eric K Nakakura

Mentions

9
Peak: 4 in Mar 2025
across 2 sources since Oct 2022

Extended reach

29,642
potential audience

Total likes

44

Video views

12,056

Mentions per month

Oct 2022 – Jul 2025

Where it's discussed

  • YouTube8 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

The discussions reveal a general consensus supporting the study's finding that minimally invasive approaches have similar long-term results, evidenced by phrases like 'offers similar outcomes' and mentions of specific scenarios like bulky masses. The tone is primarily informative with cautious acknowledgment of certain cases where open surgery might be chosen, indicating moderate engagement and impact.

AgreementModerate agreement

Most discussions agree that minimally invasive surgery offers comparable outcomes to open surgery for ileal neuroendocrine tumors, though some mention specific cases where open might still be preferable.

InterestModerate interest

Participants show a moderate level of curiosity, focusing on the implications for surgical choices and patient outcomes rather than deep technical details.

EngagementModerate engagement

Comments reflect an active interest, with some posts debating best practices, but few demonstrate lengthy or in-depth analysis.

ImpactNeutral impact

The discussions suggest a modest recognition of the study's influence on surgical decision-making, though they mainly interpret it as confirmation of existing understanding.

Abstract in brief

  • The study investigates long-term survival outcomes of minimally invasive surgery (MIS) versus open surgery for ileal neuroendocrine tumors (i-NETs) in a cohort of 168 patients.
  • Overall survival rates between patients who underwent MIS and those who had open surgery were found to be similar, with median survival times of 99 months and 103 months, respectively.
  • MIS shows comparable short- and long-term outcomes for i-NETs, suggesting it can be a viable alternative, especially when bulky masses or liver resection are not required.

Top posts

Most liked on X and Bluesky
Society of Surgical Oncology
@SocSurgOnc · X

New study in @AnnSurgOnc: Minimally invasive surgery for ileal neuroendocrine tumors offers similar long-term outcomes to open surgery. Open surgery may be better for bulky mesenteric masses or concurrent liver resection.

Aug 10, 2024 · 4 likes · 17,589 followers View post →

All mentions

Society of Surgical Oncology
@SocSurgOnc · X

New study in @AnnSurgOnc: Minimally invasive surgery for ileal neuroendocrine tumors offers similar long-term outcomes to open surgery. Open surgery may be better for bulky mesenteric masses or concurrent liver resection.

Aug 10, 2024 · 4 likes · 17,589 followers View post →